Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

Zinc and vitamin A supplementation in indigenous Australian children hospitalized with lower respiratory tract infection: A randomised controlled trial

Chang, Anne B., Torzillo, Paul J., Stewart, Peter M., Boyce, Naomi C., White, Andrew V., Wheaton, Gavin, R., Purdie, David M., Wakerman, John and Valery, Patricia C. (2006). Zinc and vitamin A supplementation in indigenous Australian children hospitalized with lower respiratory tract infection: A randomised controlled trial. Medical Journal of Australia,184(3):107-112.

Document type: Journal Article
Citation counts: Google Scholar Search Google Scholar

IRMA ID 10491xPUB119
Title Zinc and vitamin A supplementation in indigenous Australian children hospitalized with lower respiratory tract infection: A randomised controlled trial
Author Chang, Anne B.
Torzillo, Paul J.
Stewart, Peter M.
Boyce, Naomi C.
White, Andrew V.
Wheaton, Gavin, R.
Purdie, David M.
Wakerman, John
Valery, Patricia C.
Journal Name Medical Journal of Australia
Publication Date 2006
Volume Number 184
Issue Number 3
ISSN 0025-729X   (check CDU catalogue open catalogue search in new window)
Start Page 107
End Page 112
Total Pages 6
Place of Publication Australia
Publisher Australasian Medical Publishing Company Pty. Ltd.
Field of Research 1199 - Other Medical and Health Sciences
HERDC Category C1 - Journal Article (DEST)
Abstract Objective:
To evaluate the efficacy of supplementation with zinc and vitamin A in Indigenous children hospitalised with acute lower respiratory infection (ALRI).
Design:
Randomised controlled, 2-by-2 factorial trial of supplementation with zinc and vitamin A.
Setting and participants:
187 Indigenous children aged < 11 years hospitalised with 215 ALRI episodes at Alice Springs Hospital (April 2001 to July 2002).
Interventions:
Vitamin A was administered on Days 1 and 5 of admission at a dose of 50 000 IU (infants under 12 months), or 100 000 IU; and zinc sulfate was administered daily for 5 days at a daily dose of 20 mg (infants under 12 months) or 40 mg.
Main outcome measure:
Time to clinical recovery from fever and tachypnoea, duration of hospitalisation, and readmission for ALRI within 120 days.
Results:
There was no clinical benefit of supplementation with vitamin A, zinc or the two combined, with no significant difference between zinc and no-zinc, vitamin A and no-vitamin A or zinc + vitamin A and placebo groups in time to resolution of fever or tachypnoea, or duration of hospitalisation. Instead, we found increased morbidity; children given zinc had increased risk of readmission for ALRI within 120 days (relative risk, 2.4; 95% CI, 1.003–6.1).
Conclusion:
This study does not support the use of vitamin A or zinc supplementation in the management of ALRI requiring hospitalisation in Indigenous children living in remote areas. Even in populations with high rates of ALRI and poor living conditions, vitamin A and zinc therapy may not be useful. The effect of supplementation may depend on the prevalence of deficiency of these micronutrients in the population.
Keywords developing-countries
double-blind
pneumonia
diarrhea
morbidity
diseases
 
Versions
Version Filter Type
Access Statistics: 75 Abstract Views  -  Detailed Statistics
Created: Wed, 28 Nov 2007, 14:16:08 CST